A Phase II Study of 5-Azacytidine (AZA) and Venetoclax As Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission
暂无分享，去创建一个
M. Konopleva | G. Garcia-Manero | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | J. Burger | N. Pemmaraju | N. Jain | N. Short | A. Ferrajoli | Y. Alvarado | K. Sasaki | P. Bose | H. Kantarjian | G. Issa | K. Chien | M. Yilmaz | A. Bazinet | Debra Bull Linderman